INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 18, 2022 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 335 | -- | 52,795 |
| Feb 25, 2021 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 435 | -- | 24,280 |
| Feb 26, 2020 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 750 | -- | 20,979 |
| May 24, 2019 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 1,300 | -- | 21,150 |
| Nov 07, 2016 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 7,876 | -- | 23,950 |
| Feb 19, 2016 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 1,500 | -- | 40,470 |
| May 28, 2015 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Bona fide gift | 1,000 | -- | 16,405 |
| Nov 18, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Bona fide gift | 250 | -- | 18,584 |
| Nov 18, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Bona fide gift | 500 | -- | 4,871 |
| Jan 13, 2003 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Bona fide gift | 250 | $19.65 | 15,482 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.